Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)

O'Leary, C; Gasper, H; Sahin, KB; Tang, M; Kulasinghe, A; Adams, MN; Richard, DJ; O'Byrne, KJ

O'Leary, C (corresponding author), Princess Alexandra Hosp, Brisbane, Qld 4000, Australia.; O'Leary, C (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Fac Hlth, Brisbane, Qld 4000, Australia.; O'Leary, C (corresponding author), Translat Res Inst, Canc & Ageing Res Program, Brisbane, Qld 4000, Australia.

PHARMACEUTICALS, 2020; 13 (10):

Abstract

Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers in non-small-cell lung cancer (NSCLC). Significant development......

Full Text Link